Will CMS Find Aducanumab Reasonable and Necessary for Alzheimer Disease After FDA Approval? JAMA Schulman, K. A., Greicius, M. D., Richman, B. 2021

View details for DOI 10.1001/jama.2021.11768

View details for PubMedID 34279572